Skip to content

Opening book details…

About this Medicine article

216 Preclinical characterization of EMD 1214063 - a selective c-Met kinase inhibitor in clinical phase 1 by O. Schadt; D. Dorsch; F. Stieber; A. Blaukat; F. Bladt; C. Fittschen; M. Meyring; M. Friese-Hamim; C. Knuehl; U. Graedler is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
O. Schadt; D. Dorsch; F. Stieber; A. Blaukat; F. Bladt; C. Fittschen; M. Meyring; M. Friese-Hamim; C. Knuehl; U. Graedler
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
Published
2010
Language
EN
Field
Medicine (Health Sciences)

More by O. Schadt; D. Dorsch; F. Stieber; A. Blaukat; F. Bladt; C. Fittschen; M. Meyring; M. Friese-Hamim; C. Knuehl; U. Graedler

Browse all works by O. Schadt; D. Dorsch; F. Stieber; A. Blaukat; F. Bladt; C. Fittschen; M. Meyring; M. Friese-Hamim; C. Knuehl; U. Graedler